ANDA 78841, held by Apotex. Donepezil Hydrochloride.
As of Nov 16, 2026, ANDA 78841 (Donepezil Hydrochloride), held by Apotex, was first approved by FDA on Jun 2, 2011, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 2, 2011 | Original application | Approved | None posted |
| Donepezil Hydrochloride5MG · tablet;oral | Donepezil Hydrochloride | Discontinued |
| Donepezil Hydrochloride10MG · tablet;oral | Donepezil Hydrochloride | Discontinued |
| Oct 4, 2016 | Supplement 5Labeling · Standard review | Approved | None posted |
| Nov 3, 2014 | Supplement 4Labeling · Standard review | Approved | None posted |
| Sep 20, 2013 | Supplement 1Labeling · Standard review | Approved | None posted |
| Sep 20, 2013 | Supplement 2Labeling · Standard review | Approved | None posted |
| Jun 2, 2011 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters